NASDAQ:SPRY | Income Statement | ARS Pharmaceuticals, Inc.

Complete source-backed income-statement history.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2026-06-30$33.66M$4.7M$77.58M$95.12M-$61.47M-$62.34M-$0.63-$0.6399,312,52699,312,526
2026-03-31$22.68M$4.34M$72.2M$82.83M-$60.15M-$60.62M-$0.61-$0.6199,296,40899,296,408
2025-12-31$28.09M$3.44M$59.96M$69.55M-$41.47M-$41.32M-$0.42-$0.42153,742153,742
2025-09-30$32.5M$2.75M$74.75M$85.69M-$53.19M-$51.15M-$0.52-$0.5298,807,60098,807,600
2025-06-30$15.72M$4.04M$54.31M$63.33M-$47.61M-$44.88M-$0.46-$0.4698,361,77198,361,771
2025-03-31$7.97M$2.95M$41.1M$45.15M-$37.18M-$33.94M-$0.35-$0.3598,060,63698,060,636
2024-12-31$86.58M$3.03M$35.49M$39.38M$47.2M$49.93M$0.51$0.51153,8435,608,010
2024-09-30$2.07M$4.42M$19.28M$23.82M-$21.75M-$19.13M-$0.20-$0.2097,032,33197,032,331
2024-06-30$500,000.00$6.9M$8.94M$15.84M-$15.34M-$12.52M-$0.13-$0.1396,827,68796,827,687
2024-03-31$0.00$5.23M$7.96M$13.19M-$13.19M-$10.29M-$0.11-$0.1196,486,48096,486,480
2023-12-31$0.00$3.4M$6.82M$10.23M-$10.23M-$7.17M-$0.07-$0.07305,310305,310
2023-09-30$0.00$3M$14.98M$17.98M-$17.98M-$14.87M-$0.16-$0.1695,576,62795,576,627
2023-06-30$10,000.00$7.31M$181,000.00$20.61M-$20.6M-$17.37M-$0.18-$0.1894,911,26894,911,268
2023-03-31$20,000.00$6.55M$337,000.00$18.73M-$18.71M-$14.96M-$0.16-$0.1694,227,31394,227,313
2022-12-31$0.00$4.71M$15.44M-$15.44M-$14.43M-$0.21-$0.219,377,5279,377,527
2022-09-30$189,000.00$3.89M$6.82M-$6.63M-$6.58M-$0.21-$0.2130,755,12330,755,123
2022-06-30$464,000.00$4.35M$6.81M-$6.34M-$6.42M-$0.21-$0.2130,606,77330,606,773
2022-03-31$663,000.00$5.42M$7.76M-$7.1M-$7.25M-$0.24-$0.2430,369,41330,369,413
2021-12-31-$25.36M-$41.12M$46.62M$45.78M$1.19$1.19-6,012,414-6,012,414
2021-09-30$15.64M$22.68M-$22.68M-$22.66M-$0.65-$0.6535,001,46635,001,466
2021-06-30$17.75M$24.51M-$24.51M-$24.5M34,876,050
2021-03-31$12.24M$18.89M-$18.89M-$18.87M34,773,950
2020-12-31$8.84M$13.1M-$13.1M-$13.09M2,235,011
2020-09-30$6.2M$8.11M-$8.11M-$8.12M678,048
2020-06-30$5.13M$6.46M-$6.46M-$6.47M670,451
2020-03-31$4.41M$5.24M-$5.24M-$5.28M669,033

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2025-12-31$84.28M$13.18M$230.12M$263.73M-$179.45M-$171.38M-$80,000.00-$171.3M-$1.74-$1.7498,566,48198,566,481
2024-12-31$89.15M$19.58M$71.68M$92.23M-$3.08M$8.29M$288,000.00$8M$0.08$0.0896,936,661102,390,828
2023-12-31$30,000.00$0.00$20.27M$47.28M$67.55M-$67.52M-$54.37M$0.00-$54.37M-$0.57-$0.5795,215,32295,215,322
2022-12-31$1.32M$18.38M$603,000.00$36.83M-$35.52M$834,000.00$0.00-$34.68M-$0.87-$0.8739,956,04339,956,043
2021-12-31$5.51M$20.27M$24.96M-$19.45M-$789,000.00$0.00-$20.24M-$0.70-$0.7028,872,24228,872,242
2020-12-31$24.58M$32.92M-$32.92M$0.00-$32.95M2,907,542

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.